• Citer

Final results from the phase Ia/Ib study of the novel bromodomain and extra-terminal domain inhibitor, BI 894999, in patients with advanced solid tumors or diffuse large B-cell lymphoma

par Lauer, Ulrich U.M.;Awada, Ahmad ;Postel-Vinay, Sophie;Shapiro, Geoffrey G.I.;Thiéblemont, Catherine;Piha-Paul, S.A.;Paik, Paul P.K.;Shepard, Dale D.R.;Docampo, Lara Iglesias;Galot, Rachel;Rottey, Sylvie;Sadrolhefazi, Behbood;Marzin, Kristell;Musa, Hanny;Schöffski, Patrick
Référence ESMO Open, 10, 5, 104499
Publication Publié, 2025

Article révisé par les pairs

• Accès en ligne
• Détails
• Contenu
• Statistiques

Titre:	Final results from the phase Ia/Ib study of the novel bromodomain and extra-terminal domain inhibitor, BI 894999, in patients with advanced solid tumors or diffuse large B-cell lymphoma
Auteur:	Lauer, Ulrich U.M.; Awada, Ahmad; Postel-Vinay, Sophie; Shapiro, Geoffrey G.I.; Thiéblemont, Catherine; Piha-Paul, S.A.; Paik, Paul P.K.; Shepard, Dale D.R.; Docampo, Lara Iglesias; Galot, Rachel; Rottey, Sylvie; Sadrolhefazi, Behbood; Marzin, Kristell; Musa, Hanny; Schöffski, Patrick
Informations sur la publication:	ESMO Open, 10, 5, 104499
Statut de publication:	Publié, 2025
Sujet CREF:	Cancérologie
Mots-clés:	bromodomain and extraterminal domain inhibitor
	diffuse large B-cell lymphoma
	dose escalation
	dose-limiting toxicities
	solid tumor
Note générale:	SCOPUS: ar.j
Langue:	Anglais
Identificateurs:	urn:issn:2059-7029
	info:doi/10.1016/j.esmoop.2025.104499
	info:pii/S2059702925003680
	info:scp/105001943134